These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2348856)

  • 1. Human gene therapy. Approval next time round?
    Gershon D
    Nature; 1990 Jun; 345(6275):468. PubMed ID: 2348856
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adenosine deaminase deficiency and severe combined immunodeficiency].
    Ueland PM
    Tidsskr Nor Laegeforen; 1980 Feb; 100(5):274-6. PubMed ID: 7385150
    [No Abstract]   [Full Text] [Related]  

  • 3. Iron overload as a result of transfusion therapy in a patient with adenosine deaminase deficiency.
    Hopp RJ; Kobayashi RH; Antonson DL
    Nebr Med J; 1985 Mar; 70(3):95-7. PubMed ID: 3982555
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy of genetic disorders.
    Hirschhorn R
    N Engl J Med; 1987 Mar; 316(10):623-4. PubMed ID: 3807956
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular pathology of immunological deficiency. Apropos of adenosine deaminase deficiency and nucleoside phosphorylase deficiency].
    Souillet G
    Pediatrie; 1975; 30(7):746-56. PubMed ID: 1105387
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow transplantation in a case of severe combined immunodeficiency with adenosine deaminase deficiency [proceedings].
    Souillet G; Cret L; Freycon F; Dischino M; Touraine JL; Chataing B; Betuel H; Manel AM; Jeune M
    Pathol Biol (Paris); 1978 Jan; 26(1):30-1. PubMed ID: 29271
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transplantation of T cell-depleted marrow from parents in a case of severe combined immunodeficiency with adenosine deaminase deficiency].
    Yamagami M; Matsuda A; Nakarai T; Katayama K; Saigawa Y; Horita S; Miura M; Kato E; Koizumi S; Taniguchi N
    Rinsho Ketsueki; 1987 Sep; 28(9):1669-74. PubMed ID: 3325660
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy.
    Hirschhorn R
    Birth Defects Orig Artic Ser; 1983; 19(3):73-81. PubMed ID: 6418227
    [No Abstract]   [Full Text] [Related]  

  • 9. Dipyridamole and intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency.
    Ammann AJ; Cowan MJ; Martin DW; Wara DW
    Birth Defects Orig Artic Ser; 1983; 19(3):117-20. PubMed ID: 6652234
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.
    Davies EG; Levinsky RJ; Webster DR; Simmonds HA; Perrett D
    Clin Exp Immunol; 1982 Nov; 50(2):303-10. PubMed ID: 6983936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine deaminase and immunodeficiency.
    Cohen F
    Birth Defects Orig Artic Ser; 1975; 11(1):124-7. PubMed ID: 1148377
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial:A.D.A. deficiency.
    Lancet; 1976 Apr; 1(7965):895-6. PubMed ID: 58156
    [No Abstract]   [Full Text] [Related]  

  • 13. [Primary immunodeficiencies and purine metabolism].
    Romo Cortina A; Lorente Toledano F; Salazar Villalobos V
    Rev Clin Esp; 1985 Oct; 177(6):247-53. PubMed ID: 3001848
    [No Abstract]   [Full Text] [Related]  

  • 14. Testing newborns for adenosine deaminase deficiency not cost effective.
    Hodes RM
    N Engl J Med; 1981 Dec; 305(25):1530. PubMed ID: 6795506
    [No Abstract]   [Full Text] [Related]  

  • 15. Chondroosseous histopathology in adenosine deaminase deficient combined immunodeficiency disease.
    Kaitila I; Rimoin DL; Cedarbaum SD; Stiehm ER; Lachman RS
    Birth Defects Orig Artic Ser; 1976; 12(6):115-21. PubMed ID: 974246
    [No Abstract]   [Full Text] [Related]  

  • 16. Accumulation of deoxyribonucleotides as a possible mediator of immunosuppression in hereditary deficiency of adenosine deaminase.
    Bluestein HG; Willis RC; Thompson LF; Matsumoto S; Seegmiller JE
    Trans Assoc Am Physicians; 1978; 91():394-402. PubMed ID: 314193
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adenosine deaminase deficit in severe combined immunodeficiency (author's transl)].
    Español Borén T; Jacques Castro G; Torán Fuentes N; Vives-Corrons JL
    Sangre (Barc); 1981; 26(6):1129-38. PubMed ID: 6805082
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
    Hirschhorn R; Ratech H
    Curr Top Hematol; 1983; 4():1-35. PubMed ID: 6413135
    [No Abstract]   [Full Text] [Related]  

  • 19. Somatic cell gene therapy: the model of adenosine deaminase deficiency.
    Van Beusechem VW; Kukler A; Bakx TA; Valerio D
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():133-6. PubMed ID: 2697426
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adenosine-deaminase defect of erythrocytes and combined immune defect: a new metabolic disease. First experiences with screening tests of the disease and quantitative determination of enzyme activity].
    Szüts P; Havass Z; Boda D
    Orv Hetil; 1977 Oct; 118(41):2457-60. PubMed ID: 917532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.